Burns Matteson Capital Management LLC Lowers Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Burns Matteson Capital Management LLC cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 4.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,390 shares of the medical device company’s stock after selling 384 shares during the period. Burns Matteson Capital Management LLC’s holdings in Cooper Companies were worth $679,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Ashton Thomas Securities LLC acquired a new stake in Cooper Companies in the third quarter valued at approximately $25,000. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the 4th quarter valued at $33,000. Covestor Ltd increased its holdings in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. raised its position in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares during the period. Finally, West Financial Advisors LLC purchased a new position in Cooper Companies during the fourth quarter valued at $49,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Analyst Ratings Changes

COO has been the subject of a number of research reports. Morgan Stanley cut their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Wells Fargo & Company boosted their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Down 1.8 %

Shares of NASDAQ COO opened at $93.57 on Monday. The company has a market capitalization of $18.67 billion, a P/E ratio of 47.98, a P/E/G ratio of 2.41 and a beta of 1.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a 50 day simple moving average of $94.99 and a 200-day simple moving average of $99.85. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the firm earned $0.87 earnings per share. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.